CRISPR Therapeutics AG Collaboration Agreements

6 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to the Strategic Collaboration and License Agreement dated March 17, 2021, between CRISPR Therapeutics AG and Vertex Pharmaceuticals Incorporated
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
2021
Amendment No. 2 to Research Collaboration Agreement by and between CRISPR Therapeutics AG and ViaCyte, Inc., dated as of October 21, 2019
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
2020
Amendment No. 1 to Research Collaboration Agreement by and between CRISPR Therapeutics AG and ViaCyte, Inc., dated as of April 30, 2019
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
2020
Strategic Collaboration and License Agreement dated June 6, 2019, between CRISPR Therapeutics AG and Vertex Pharmaceuticals Incorporated
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
MA
2019
Amendment No. 2 to the Strategic Collaboration, Option and License Agreement by and between, on the one hand, Vertex Pharmaceuticals Incorporated and Vertex Pharmaceuticals...
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
2019
Amendment No. 1 to the Strategic Collaboration, Option and License Agreement by and between, on the one hand, Vertex Pharmaceuticals Incorporated and Vertex Pharmaceuticals...
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
MA
2017